Retinal nerve fiber layer thickness is associated with episodic memory deficit in mild cognitive impairment patients

Current Alzheimer Research

Volumn 11, Issue 3, 2014, Pages 259-266

  Shen, Yuan ^a   Liu, Liang ^b   Cheng, Yan ^a   Feng, Wei ^a   Shi, Zhongyong ^a   Zhu, Yikang ^c   Wu, Wenyuan ^a   Li, Chunbo ^c  

^a TONGJI UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Episodic memory; Mild cognitive impairment; Retinal nerve fiber layer thickness

Indexed keywords

AGED; AMNESIA; ARTICLE; COGNITION; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINAL NERVE FIBER LAYER THICKNESS; STORYTELLING; WORD LIST RECALL;

AGED; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MEMORY, EPISODIC; MILD COGNITIVE IMPAIRMENT; NERVE FIBERS; NEUROPSYCHOLOGICAL TESTS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL PATHWAYS;

EID: 84897417198     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011666140131114418     Document Type: Article

References (36)

1. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137-52 (2011).
2. Jack C, Knopman D, Jagust W, Shaw L, Aisen P, Weiner M, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9: 119-28 (2010).
3. Price J, Morris J. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45: 358-68 (1999).
4. Sperling R, Aisen P, Beckett L, Bennett D, Craft S, Fagan A, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 280-92 (2011).
5. McKhann G, Knopman D, Chertkow H, Hyman B, Jack C, Kawas C, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-9 (2011).
6. Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-8 (1999).
7. Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnosis guidelines for Alzheimer's disease. Alzheimers Dement 7: 270-9 (2011).
8. Sunderland T, Linker G, Mirza N, Putnam K, Friedman D, Kimmel L, et al. Decreased beta-amyloid 1-42 and increased tau level in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289: 2094-103 (2003).
9. Landau S, Harvey D, Madison C, Koeppe R, Reiman E, Foster N, et al. Association between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32: 1207-18 (2011).
10. Morra J, Tu Z, Apostolova L, Green A, Avedissian C, Madsen S, et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. NeuroImage 45: s3-15 (2009).
11. Valenti D. Alzheimer's disease: Visual system review. Optometry 81:12-21 (2010).
12. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 420: 97-9 (2007).
13. Kesler A, Vakhapova V, Korczyn A, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosur 113: 523-6 (2011).
14. Hedges T, Perez G, Speigelman D, Barbas N, Peli E, Yardley C. Retinal nerve fiber layer abnormalities in Alzheimer's disease. Acta Ophthlmol Scand 74: 271-5 (1996).
15. Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci Lett 9: 69-72 (2010).
16. thed. Washington, DC.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-44 (1984).
18. Katzman R, Zhang MY, Ouang Y, Wang Z, Liu W, Yu E, et al. A Chinese version of the mini-mental state examination: Impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol 41: 971-8 (1988).
19. Chen P, Yu ES, Zhang MY, Zhang M, Liu WT, Hill R, et al. ADL dependence and medical conditions in Chinese older persons: a population-based survey in Shanghai, China. J Am Soc Geriatr Dent 43: 378-83 (1995).
20. Cheng Y, Wu WY, Wang JQ, Feng W, Wu X, Li C. Reliability and validity of the repeatable battery for the assessment of neuropsychological status in community-dwelling elderly. Arch Med Sci 7: 850-7 (2011).
21. Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-8 (1999).
22. Li CB, Wu WY, Jin H, Zhang X, Xue H, He Y, et al. Successful aging in Shanghai, China: definition, distribution and related factors. Int Psychogeriatr 18: 551-63 (2006).
23. Ma F, Wang T, Yin J, Bai X, Zhang X, Meng J, et al. A casecontrol study on the influencing factors to mild cognitive impairment among the community-based elderly population. Chin J Epidemiol 29: 873-7 (2008).
24. Zhang MY, Katzman R, Salmon D, Jin H, Cai G, Wang Z, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 27: 428-37 (1990).
25. Zhou DF, Wu CS, Qi H, Fan J, Sun X, Como P, et al. Prevalence of dementia in rural China: impact of age, gender and education. Acta Neurol Scand 114: 273-80 (2006).
26. Sahadevan S, Lim J, Tan N, Chan S. Psychometric identification of early Alzheimer Disease in an elderly Chinese population with differing educational levels. Alzheimer Dis Assoc Disord 16: 65-72 (2001).
27. Tzamalis A, Kynigopoulos M, Schlote T, et al. Improved reproducibility of retinal nerve fiber layer thickness measurements with the repeat-scan protocol using the Stratus OCT in normal and glaucomatous eyes. Greafes Arch Clin Exp Ophthalmol 247: 245-52 (2009).
28. Cheung C, Leung C, Lin D, Pang C, Lam D. Relationship between retinal nerve fiber layer measurement and signal strength in optical coherence tomography. Ophthalmology 115: 1347-51 (2008).
29. Zhang BH, Tan YL, Zhang WF, Wang Z, Yang G, Shi C, et al. Repeatable battery for the assessment of neuropsychological status as screening test in Chinese: reliability and validity. Chinese Ment Health J 22: 865-9 (2008).
30. Lim ML, Collinson SL, Feng L, Nq TP. Cross-cultural application of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): performances of elderly Chinese Singaporeans. Clin Neuropsychol 24: 811-26 (2010).
31. Yang GG, Tian J, Tan YL, Wang Z, Zhang X, Zhang W, et al. The application performance of the repeatable battery for the assessment of neuropsychological status among normal persons in Beijing. Chinese Ment Health J 24: 926-31 (2010).
32. Grubbs FE. Procedures for detecting outlying observations in samples. Technometrics 11: 1-21 (1969).
33. Parisi V. Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease. Semin Ophthalmo 18: 50-7 (2003).
34. Iseri P, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26: 18-24 (2006).
35. Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33:58-61 (2013).
36. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 48: 2285-9 (2007).